$96 Evergreen TK4041NG Compatible With Honda Accord CR-V Element K24 Automotive Replacement Parts Engines Engine Parts Evergreen TK4041NG Compatible With Honda Accord Direct stock discount CR-V Element K24 solcabachuela.com,Automotive , Replacement Parts , Engines Engine Parts,$96,Accord,Element,Honda,Compatible,/goshawk140922.html,Evergreen,CR-V,K24,With,TK4041NG solcabachuela.com,Automotive , Replacement Parts , Engines Engine Parts,$96,Accord,Element,Honda,Compatible,/goshawk140922.html,Evergreen,CR-V,K24,With,TK4041NG $96 Evergreen TK4041NG Compatible With Honda Accord CR-V Element K24 Automotive Replacement Parts Engines Engine Parts Evergreen TK4041NG Compatible With Honda Accord Direct stock discount CR-V Element K24

Evergreen TK4041NG Compatible Max 85% OFF With Honda Accord Direct stock discount CR-V Element K24

Evergreen TK4041NG Compatible With Honda Accord CR-V Element K24

$96

Evergreen TK4041NG Compatible With Honda Accord CR-V Element K24

|||

Product description

This item includes:
1 Timing cam chain (176 link)
1 Cam chain tensioner
1 Upper fixed guide rail
1 Right tensioning guide rail
1 Left side fixed guide rail
1 Oil pump chain (62 link)
1 Oil pump tensioner
1 Oil pump guide rail
Gear or sprocket are not included

Part Numbers: TK4041NG

Part Fitments:
2004-2007 ACURA TSX VTEC 2.4L 2354CC L4 DOHC, (16 VALVE), ENG. CODE "K24A2"
2003-2005 HONDA ACCORD VTEC 2.4L 2354CC L4 DOHC, (16 VALVE), ENG. CODE "K24A4"
2006-2007 HONDA ACCORD VTEC 2.4L 2354CC L4 DOHC, (16 VALVE), ENG. CODE "K24A8"
2002-2007 HONDA CR-V VTEC 2.4L 2354CC L4 DOHC, (16 VALVE), ENG. CODE "K24A1"
2003-2006 HONDA ELEMENT VTEC 2.4L 2354CC L4 DOHC, (16 VALVE), ENG. CODE "K24A4"
2007 HONDA ELEMENT VTEC 2.4L 2354CC L4 DOHC, (16 VALVE), ENG. CODE "K24A8"


From the manufacturer

Evergreen TK4041NG Compatible With Honda Accord CR-V Element K24

CURRENT ISSUE
September, 2021

No. 106 (9)

2020 Impact Factor: 9.941 Submission > Acceptance: 52 days
ARTICLES IN THREE SENTENCES
Article

Long-term outcomes from the phase II L-MIND study of tafasitamab (MOR208) plus lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma

This open-label, single-arm study investigated the long-term efficacy of tafasitamab plus lenalidomide in 81 patients with relapsed/refractory diffuse large B-cell lymphoma. The response rate was 57.5%, including complete responses in 40.0% of patients, and the median duration of response was 43.9 months. This treatment is a valuable option for patients not eligible for autologous stem-cell transplantation.

Johannes Duell et al.

Case Report

Clinical genomic profiling of novel grey zone lymphoma paired lesions with sequential central nervous system involvement in two adolescent patients

Grey zone lymphoma is a B-cell lymphoma, unclassifiable, with features intermediate between those of large B-cell lymphoma and classic Hodgkin lymphoma. The in-depth study of the two adolescent patients described in this case report expands the clinicopathological and genomic spectrum of this rare pediatric disease. Moreover, it provides information on their response to treatment.

Cagla Y. Benkli et al.

Article

CAMT-MPL: congenital amegakaryocytic thrombocytopenia caused by MPL mutations - heterogeneity of a monogenic disorder - a comprehensive analysis of 56 patients

The clinical picture of 56 patients with congenital amegakaryocytic thrombocytopenia due to MPL mutations was much more varied than previously thought. Twenty-five per cent of them had no signs of thrombocytopenia at birth, and 50% had non-hematologic defects. Pancytopenia developed in (nearly) all patients and hematopoietic stem-cell transplantation was effective in 87% of cases.

Manuela Germeshausen et al.

Article

Oxidative stress activates red cell adhesion to laminin in sickle cell disease

Sickle red blood cells exhibit abnormal adhesion to laminin mediated by Lu/BCAM protein at their surface. This study provides evidence of the involvement of oxidative stress in post-translational modifications of Lu/BCAM which impact the protein’s distribution and cis-interaction with glycophorin C at the cell surface activating its adhesive function in dense sickle red cells. The authors speculate that antioxidant drugs might attenuate this phenomenon.

Maria Alejandra Lizarralde-Iragorri et al.

TAKE ADVANTAGE FROM HAEMATOLOGICA